Curi Bio logo

Curi Bio

curibio.com

Curi Bio provides integrated platforms that combine advanced 3D human tissue models, biosystems for functional analysis, and AI-enabled data analytics to support drug discovery and preclinical R&D. Its products and services are used by pharmaceutical and biotechnology companies to improve the predictive accuracy of drug safety, efficacy, and potency assessments, with a focus on cardiac, skeletal muscle, and disease models. The organization aims to accelerate the development of next-generation human medicines by integrating human cells, systems, and data.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2015
Type
Corporation Seattle business license
Employees
51
Registered name
Nanosurface Biomedical Inc Seattle business license
Stage
Series B
Founders
Elliot Fisher

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Curi Bio

See all 11

Curi Bio raises $10M to advance iPSC-based 3D tissue drug-discovery platforms including Mantarray

Seattle-based Curi Bio raised $10 million in Series A financing to advance its human iPSC-based drug discovery platforms, including 3D engineered tissue products like Mantarray and Cytostretcher. The company provides customized assay and screening services for cardiac, musculoskeletal and neuromuscular models and has prior funding including $6M this spring and over $6M in NIH grants.

By Curi Bio

People

  • Elliot Fisher Co-Founder & Chief Business Officer
  • Michael Cho Executive, Chief Strategy Officer
  • Nicholas Geisse Executive, Chief Executive Officer

Online

Questions about Curi Bio

What is Curi Bio?

Curi Bio is a startup based in Seattle, Washington, US that provides integrated platforms combining 3D human tissue models, functional analysis biosystems, and AI-enabled data analytics for drug discovery and preclinical R&D.

What is Curi Bio known for?

Curi Bio is known for tools that help pharmaceutical and biotechnology companies assess drug safety, efficacy, and potency, with a focus on cardiac, skeletal muscle, and disease models.

What has Curi Bio been in the news for?

GeekWire reported in December 2025 on Curi Bio’s work to advance 3D tissue drug discovery platforms. In December 2021, GeekWire covered Curi Bio’s iPSC-based 3D tissue drug-discovery platforms, including Mantarray.

Who are the people behind Curi Bio?

Elliot Fisher is co-founder and chief business officer at Curi Bio. Nicholas Geisse is chief executive officer, and Michael Cho is chief strategy officer.

Who invested in Curi Bio, and how much has it raised?

Members of Seattle Flow see Curi Bio's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Curi Bio based?

Curi Bio is based in Seattle, Washington, US.